secwatch.observer — SEC 8-K summary
======================================

Issuer:     GeoVax Labs, Inc. (GOVX)
CIK:        0000832489
Form:       8-K
Filed at:   2026-10-27T13:00:43+00:00
Accession:  0001437749-26-033566
Event type: debt
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01, 5.02, 2.03, 3.03, 7.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

GeoVax signs $1M lender-discretion revolver at 12%; lender nominees take 3 of 5 board seats
--------------------------------------------------------------------------------

- Unsecured $1,000,000 revolver with Bowery Consulting Group at 12% per annum, maturing 12 months after closing; no amounts drawn as of the filing; 16% default rate.
- Each drawdown is at the Lender's sole and absolute discretion and either party may terminate the commitment at any time, so GeoVax can give no assurance funds will be available.
- Five directors (Chase, Kollintzas, Lemerond, Morgan, Spencer) resigned Oct 23, 2026; lender nominees Brown, O'Brien and Uppal hold 3 of 5 seats and a majority of every committee.
- Nominees auto-resign if the Qualified Public Equity Offering (>=$5M) misses a 10-business-day post-S-1 deadline or $10M Required Additional Financing is not done by Dec 31, 2026.
- Covenants bar dividends, buybacks and new officer/consultant compensation without lender consent; lender gets a 10-day right of first refusal on new debt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/832489/000143774926033566/0001437749-26-033566-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/832489/000143774926033566/govx20261026_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-033566

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer